Dr. Saeid Babaei

Virotek Biosciences is a Canadian biopharmaceutical company led by serial entrepreneur Dr. Saeid Babaei, specializing in the development of therapeutic and diagnostic solutions for infectious diseases and oncology. The company utilizes a proprietary Peptide Computational Platform to design neutralizing peptides, with its lead program focused on targeting the SARS-CoV-2 spike protein for the treatment of COVID-19. Virotek also operates a diagnostics subsidiary, ViroNetix, which provides large-scale, Health Canada-approved PCR testing and screening services. As of 2026, the company has integrated advanced multi-omic sequencing technologies to enhance its R&D capabilities and serves as a strategic partner for AI-enabled clinical asset evaluation in the biotechnology sector.